Suppression of SOX2 in BC has been possible with artificial zinc fingers proteins (ZFP) linked to epigenetic modifiers, such as DNA methyltransferase 3A (ZF-DNMT3A) designed to target the SOX2 promoter [46,48]. Here, SOX2 is linked to breast cancer.